FDA Decides First Sex-Drive Pill for Women Worth the Risks

Updated on

Meet Addyi, the FDA-Approved Women's Sex-Drive Pill

The first pill for low libido in women will go on sale in the U.S. after regulators decided that despite its modest benefit and serious side effects, the drug was worthwhile to address an affliction with no other approved treatments.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.